Skip to content

Clinical trials

Completed Schizophrenia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Germany Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20021
20036
200412
20055
20064
200710
20088
20097
20109
20119
20125
20135
20143
20153
20167
20173
20183
20191
20201
20214
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed117

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Heinrich-Heine University, Duesseldorf8
Janssen-Cilag International NV8
Universitätsklinikum Hamburg-Eppendorf6
Central Institute of Mental Health, Mannheim5
Charite University, Berlin, Germany5
Technical University of Munich5
Boehringer Ingelheim4
Hoffmann-La Roche4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia117
Psychotic Disorders29
Hallucinations6
Bipolar Disorder5
Cognition Disorders5
Depressive Disorder5
Schizophrenia, Paranoid4
Anxiety Disorders3
Arrhythmias, Cardiac2
Asthma2

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.